Natalie C. Holles
CIK 1580111 · See Remarks · last filed 2026-06-24
Natalie C. Holles is a corporate insider who has filed 42 SEC Form 4 insider transactions across 8 companies since 2013. The most recent filing, for LONA, was dated Jun 24, 2026. Across all open-market trades the lifetime net is −$411.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.1M across reported positions. 1 Form 144 notice of planned sales is also on file; the latest, for THRD on Apr 11, 2024, lists the filer as an officer and director.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
THRD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE, CA 94005
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LONA | Director | — | $2.37 | — | $0 | 2 | 2026-06-24 |
| AURA | See Remarks | 1,153,962 | $7.00 | $8.08M | $0 | 1 | 2026-05-19 |
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Director | 0 | $21.53 | $0 | $0 | 6 | 2026-04-23 |
| Third Harmonic Bio, Inc. (THRD) Delisted | CEO | 1,218,836 | $5.38 | $6.56M | -$411.5K | 7 | 2025-01-17 |
| Rubius Therapeutics, Inc. (RUBY) Delisted | Director | — | $0.08 | — | $0 | 4 | 2022-05-13 |
| Allakos Inc. (ALLK) Delisted | Director | — | $0.33 | — | $0 | 2 | 2021-10-14 |
| BOLD | President and COO | 0 | $2.34 | $0 | $0 | 12 | 2020-01-15 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | SVP, Business Development | 0 | — | — | $0 | 6 | 2015-05-08 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-24 | LONA | Grant (A) | — | $0 | EDGAR |
| 2026-05-19 | AURA | Grant (A) | +1,153,962 | $0 | EDGAR |
| 2026-05-07 | LONA | Grant (A) | — | $0 | EDGAR |
| 2026-04-23 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Disp (D) | −57,310 | $0 | EDGAR |
| 2025-11-07 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | — | $0 | EDGAR |
| 2025-08-14 | — | Other (J) | −1,218,836 | $0 | |
| 2025-06-04 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-17 | Third Harmonic Bio, Inc. (THRD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-28 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-10 | Third Harmonic Bio, Inc. (THRD) Delisted | Mixed10b5-1 | — | -$161.4K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).